2D Materials and Primary Human Dendritic Cells: A Comparative Cytotoxicity Study
Source abstract
Abstract
Abstract Human health can be affected by materials indirectly through exposure to the environment or directly through close contact and uptake. With the ever‐growing use of 2D materials in many applications such as electronics, medical therapeutics, molecular sensing, and energy storage, it has become more pertinent to investigate their impact on the immune system. Dendritic cells (DCs) are highly important, considering their role as the main link between the innate and the adaptive immune system. By using primary human DCs, it is shown that hexagonal boron nitride (hBN), graphene oxide (GO) and molybdenum disulphide have minimal effects on viability. In particular, it is evidenced that hBN and GO increase DC maturation, while GO leads to the release of reactive oxygen species and pro‐inflammatory cytokines. hBN and MoS2 increase T cell proliferation with and without the presence of DCs. hBN in particular does not show any sign of downstream T cell polarization. The study allows ranking of the three materials in terms of inherent toxicity, providing the following trend: GO > hBN ≈ MoS2, with GO the most cytotoxic.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CNRS, Immunology, Immunopathology and Therapeutic Chemistry UPR 3572 University of Strasbourg, ISIS Strasbourg 67000 France
Plateforme Imagerie In Vitro de l'ITI Neurostra, CNRS UAR 3156 University of Strasbourg Strasbourg 67000 France
CNRS, ISIS Université de Strasbourg Strasbourg 67000 France
References (99)
Show source-provided references
1. 10.1126/science.110289610.1126/science.1102896 ↗
2. 10.1081/PDT-20006568410.1081/PDT-200065684 ↗
3. 10.1016/j.ijpharm.2017.10.02510.1016/j.ijpharm.2017.10.025 ↗
4. Zhang H. · Intl J Nanomedicine. · 2013 · 8 · 1783
5. 10.1385/BTER:85:1:2310.1385/BTER:85:1:23 ↗
6. 10.1038/ncomms1393610.1038/ncomms13936 ↗
7. 10.3389/fbioe.2018.0008310.3389/fbioe.2018.00083 ↗
8. 10.1021/acs.chemrev.8b0026410.1021/acs.chemrev.8b00264 ↗
9. 10.3390/s2023681710.3390/s20236817 ↗
10. 10.1021/acs.analchem.0c0340510.1021/acs.analchem.0c03405 ↗
11. 10.1021/acsami.8b2037210.1021/acsami.8b20372 ↗
12. 10.1002/chem.20140268010.1002/chem.201402680 ↗
13. 10.1021/acs.est.6b0188110.1021/acs.est.6b01881 ↗
14. 10.1002/adfm.20160517610.1002/adfm.201605176 ↗
15. 10.3389/fphy.2018.0014910.3389/fphy.2018.00149 ↗
16. 10.1021/jp103696u10.1021/jp103696u ↗
17. 10.1016/j.cclet.2016.10.01910.1016/j.cclet.2016.10.019 ↗
18. 10.1016/j.jphotobiol.2012.12.00510.1016/j.jphotobiol.2012.12.005 ↗
19. 10.1016/j.bios.2012.09.00710.1016/j.bios.2012.09.007 ↗
20. 10.1002/smll.20120194010.1002/smll.201201940 ↗
21. 10.1016/j.sna.2020.11224710.1016/j.sna.2020.112247 ↗
22. 10.1038/s41598-020-58439-z10.1038/s41598-020-58439-z ↗
23. 10.3389/fchem.2019.0011610.3389/fchem.2019.00116 ↗
24. 10.1038/am.2017.22510.1038/am.2017.225 ↗
25. 10.1088/1361-6528/ab5ba710.1088/1361-6528/ab5ba7 ↗
26. 10.1038/7973410.1038/79734 ↗
27. 10.1146/annurev.immunol.20.100301.06482810.1146/annurev.immunol.20.100301.064828 ↗
28. 10.1038/s41565-020-00810-210.1038/s41565-020-00810-2 ↗
29. 10.2217/nnm-2017-006110.2217/nnm-2017-0061 ↗
30. 10.3390/cells1001009610.3390/cells10010096 ↗
31. 10.1093/toxsci/kfab12010.1093/toxsci/kfab120 ↗
32. 10.1021/nn901478z10.1021/nn901478z ↗
33. 10.1002/smll.20120154610.1002/smll.201201546 ↗
34. 10.2147/IJN.S24353710.2147/IJN.S243537 ↗
35. 10.1002/adma.20210313710.1002/adma.202103137 ↗
36. 10.1371/journal.pone.016681610.1371/journal.pone.0166816 ↗
37. 10.1021/acs.chemmater.7b0518810.1021/acs.chemmater.7b05188 ↗
38. 10.1021/acs.chemmater.9b0290510.1021/acs.chemmater.9b02905 ↗
39. 10.1126/sciadv.160224610.1126/sciadv.1602246 ↗
40. 10.1021/acs.jpcc.0c0265710.1021/acs.jpcc.0c02657 ↗
41. 10.1039/C6NR09312D10.1039/C6NR09312D ↗
42. 10.1039/C6TA09999H10.1039/C6TA09999H ↗
43. 10.1002/smll.20100162810.1002/smll.201001628 ↗
44. 10.1002/adfm.20170245210.1002/adfm.201702452 ↗
45. 10.1016/j.tsf.2016.12.04110.1016/j.tsf.2016.12.041 ↗
46. 10.1002/anie.20160123810.1002/anie.201601238 ↗
47. 10.1007/s11051-013-2099-y10.1007/s11051-013-2099-y ↗
48. 10.1039/C8NR00333E10.1039/C8NR00333E ↗
49. 10.1088/1361-6528/aba6b310.1088/1361-6528/aba6b3 ↗
50. 10.3390/ijms2202056710.3390/ijms22020567 ↗
51. 10.1089/ars.2019.799910.1089/ars.2019.7999 ↗
52. 10.1016/j.freeradbiomed.2007.12.03710.1016/j.freeradbiomed.2007.12.037 ↗
53. 10.18632/oncotarget.2660810.18632/oncotarget.26608 ↗
54. 10.1039/C8NR02933D10.1039/C8NR02933D ↗
55. 10.4049/jimmunol.152.11.520810.4049/jimmunol.152.11.5208 ↗
56. 10.1096/fj.03-0969fje10.1096/fj.03-0969fje ↗
57. 10.4049/jimmunol.080355310.4049/jimmunol.0803553 ↗
58. 10.1074/jbc.M10925020010.1074/jbc.M109250200 ↗
59. 10.1016/j.biomaterials.2013.03.02410.1016/j.biomaterials.2013.03.024 ↗
60. 10.1016/S0065-2776(08)60509-X10.1016/S0065-2776(08)60509-X ↗
61. 10.3389/fimmu.2018.0045510.3389/fimmu.2018.00455 ↗
62. 10.1084/jem.170.3.82710.1084/jem.170.3.827 ↗
63. 10.1016/S1359-6101(03)00043-110.1016/S1359-6101(03)00043-1 ↗
64. 10.1371/journal.pone.004426610.1371/journal.pone.0044266 ↗
65. 10.1039/C9BM01691K10.1039/C9BM01691K ↗
66. 10.1039/c3nr03543c10.1039/c3nr03543c ↗
67. 10.1088/2053-1583/aa673f10.1088/2053-1583/aa673f ↗
68. 10.1038/s41598-019-42225-710.1038/s41598-019-42225-7 ↗
69. 10.3390/nano808060510.3390/nano8080605 ↗
70. 10.2217/nnm.14.2510.2217/nnm.14.25 ↗
71. 10.2147/IJN.S17030510.2147/IJN.S170305 ↗
72. 10.4049/jimmunol.175.8.502410.4049/jimmunol.175.8.5024 ↗
73. 10.1002/smll.20200219410.1002/smll.202002194 ↗
74. 10.3389/fonc.2018.0040410.3389/fonc.2018.00404 ↗
75. 10.1038/3258810.1038/32588 ↗
76. 10.1039/C9NR00846B10.1039/C9NR00846B ↗
77. 10.1016/j.chemosphere.2008.05.05410.1016/j.chemosphere.2008.05.054 ↗
78. 10.1021/nn201447910.1021/nn2014479 ↗
79. 10.1016/j.jcis.2014.07.00410.1016/j.jcis.2014.07.004 ↗
80. 10.1002/adma.20210252810.1002/adma.202102528 ↗
81. 10.1038/mi.2009.10010.1038/mi.2009.100 ↗
82. 10.1371/journal.pone.015060710.1371/journal.pone.0150607 ↗
83. 10.1002/adhm.20150060610.1002/adhm.201500606 ↗
84. 10.1080/09540105.2019.162680910.1080/09540105.2019.1626809 ↗
85. 10.1111/sji.1218910.1111/sji.12189 ↗
86. 10.1084/jem.189.12.198110.1084/jem.189.12.1981 ↗
87. 10.1016/j.tox.2009.04.03410.1016/j.tox.2009.04.034 ↗
88. 10.1038/ni149610.1038/ni1496 ↗
89. 10.1016/j.freeradbiomed.2010.01.01310.1016/j.freeradbiomed.2010.01.013 ↗
90. 10.1021/nn406454u10.1021/nn406454u ↗
91. 10.1016/j.biomaterials.2017.08.04010.1016/j.biomaterials.2017.08.040 ↗
92. 10.1016/j.neuropharm.2018.11.03010.1016/j.neuropharm.2018.11.030 ↗
93. Wang X. · Int J Nanomedicine · 2013 · 8 · 1733
94. 10.1182/blood-2006-05-01535410.1182/blood-2006-05-015354 ↗
95. 10.18632/oncotarget.2375710.18632/oncotarget.23757 ↗
96. 10.1016/j.biomaterials.2015.07.03410.1016/j.biomaterials.2015.07.034 ↗
97. 10.1038/s41565-018-0246-410.1038/s41565-018-0246-4 ↗
98. 10.1039/C4NR06538G10.1039/C4NR06538G ↗
99. 10.1016/j.colsurfb.2015.05.05310.1016/j.colsurfb.2015.05.053 ↗